The use of prostate-specific antigen kinetics to stratify risk in prostate cancer

Joseph Presti1

  • 1Director of Urologic Oncology, Stanford University School of Medicine, 875 Blake Wilbur Drive, Room CC-2217, Stanford, CA 94305, USA.

Current Urology Reports
|September 4, 2008
PubMed